Moore Simas TA, Waring ME, Sullivan GM, Liao X, Rosal MC, Hardy JR, et al
STEP trial data with semaglutide show approximately 15-17% weight loss at similar duration on 2.4mg weekly
Inflammatory Bowel Disease (IBD) Conditions such as Crohns disease and ulcerative colitis involve significant inflammation of the gut lining
Some weight-loss studies require participants to use FDA-approved medications
When semaglutide is taken as a pill, it has to pass through the digestive system before it can be absorbed, Escobar told Health
Some patients may experience what's sometimes called relative hypoglycemiablood glucose levels that are normal by clinical standards but lower than the patient's previous baseline